Autologous Segment to Dominate MEA Skin Graft Market during 2020–2028

According to a new market research study on “MEA Skin Graft Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Graft thickness, Equipment, Application, and End user,” is expected to reach US$ 117.48 million by 2028 from US$ 84.39 million in 2021. The market is estimated to grow at a CAGR of 4.8% from 2021 to 2028. The report provides trends prevailing in the MEA skin graft market along with the drivers and restraints pertaining to the market growth.Increasing number of burn injuries is the major factor driving the growth of the MEA skin graft market. However, high cost of skin grafting procedures hinders the growth of MEA skin graft market.

Countries such as UAE, and Saudi Arabia have also registered a significant number of positive patients. These regions are developing in terms of the medical industry. The countries in these regions are highly dependent on medical devices and pharmaceutical products. Therefore, countries have faced several challenges for their requirements. Initial phase of lockdown in various countries has affected the supply of many instruments in these regions. However, the lockdown has affected the supply chain of various companies in these regions. The increasing numbers of COVID-19 positive patients are becoming threats to their respective countries. The countries are facing economic crises, which have affected various businesses, including the healthcare business. The countries are majorly dependent on the imports for healthcare products. The lockdown in various countries across the world and limited transport and declined the sales of healthcare products across the world. Thus, the above-mentioned factors have to impact the skin graft market negatively.

The market for skin graft market is segmented into product, graft thickness, equipment, application, end user and country. Based on product, the market is segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. In 2020, the autologous segment held the largest share of the market. Based on graft thickness, the market is divided into split-thickness, full-thickness and composite graft. In 2020, the split thickness segment held the largest share of the market. Based on equipment, the market is segmented into dermatome, general surgical instruments, consumables, and others. In 2020, the dermatome segment held the largest share of the market. Based on application, the market is segmented into burns, extensive wound, skin cancer, and others. In 2020, the burns segment held the largest share of the market. Based on end user, the market is segmented into ambulatory surgical centers, hospitals and dermatology clinics. In 2020, the hospitals segment held the largest share of the market. Similarly, based on country, the market is bifurcated into UAE, Saudi, SA, RPMEA. UAE contributed a substantial share in 2020. 

B. Braun Melsungen AG; Integra Life Sciences Corporation; MiMedx; Organogenesis Inc; Smith & Nephew; Zimmer Biomet; are among the leading companies in the MEA skin graft market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, MiMedx Group, Inc. launched EpiCord Expandable, the latest advancement in its portfolio of products. At the core of this technology is EpiCord, which has demonstrated clinical efficacy in the treatment of diabetic foot ulcers.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com